Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Dacarbazine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dacarbazine 100mg powder for solution for injection vials
0801050L0AAAAAA
|
Dacarbazine | Dacarbazine | Malignant Disease and Immunosuppression | No data available |
|
Dacarbazine 1g powder for solution for infusion vials
0801050L0AAAEAE
|
Dacarbazine | Dacarbazine | Malignant Disease and Immunosuppression | No data available |
|
Dacarbazine 200mg powder for solution for injection vials
0801050L0AAABAB
|
Dacarbazine | Dacarbazine | Malignant Disease and Immunosuppression | No data available |
|
Dacarbazine 500mg powder for solution for infusion vials
0801050L0AAADAD
|
Dacarbazine | Dacarbazine | Malignant Disease and Immunosuppression | No data available |
|
Dacarbazine 600mg powder for solution for infusion vials
0801050L0AAACAC
|
Dacarbazine | Dacarbazine | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.